The Journal of the American Academy of Orthopaedic Surgeons

Effects and Considerations of Glucagon-like Peptide-1 Receptor Agonists in Joint Replacement Surgery

Updated

Abstract

GLP-1 receptor agonists are increasingly used for weight loss management in obese patients.

  • GLP-1 receptor agonists are primarily known for their role in glycemic control among diabetic patients.
  • There is emerging interest in the perioperative implications of GLP-1 receptor agonists for total joint arthroplasty (TJA) patients.
  • The review addresses complications and adverse effects associated with GLP-1 receptor agonist use.
  • Considerations for anesthesiologists and TJA surgeons regarding GLP-1 receptor agonists are discussed.
  • Clinical practice recommendations for GLP-1 receptor agonist use in 2025 are highlighted.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free